Overview of Regulatory Framework
The pharmaceutical industry is governed by strict regulations on elemental impurities (heavy metals) to protect patient safety. The three key documents forming the regulatory framework are:
- ICH Q3D: Guideline for Elemental Impurities — the international harmonised guideline that establishes Permitted Daily Exposures (PDEs) for 24 elements based on toxicity data.
- USP ⟨232⟩: Elemental Impurities — Limits — defines the concentration limits for elemental impurities in drug products, drug substances, and excipients based on ICH Q3D PDEs.
- USP ⟨233⟩: Elemental Impurities — Procedures — specifies the analytical procedures (ICP-OES and ICP-MS) for testing elemental impurities, including method validation requirements.
📌 Historical Context
These chapters replaced the older USP ⟨231⟩ Heavy Metals Limit Test, which used a colorimetric (sulfide precipitation) method. The legacy test was non-specific, insensitive, and could not individually quantify specific elements. Modern ICP-MS provides element-specific, quantitative analysis at much lower detection limits.
ICH Q3D — Element Classification
ICH Q3D classifies 24 target elements into four classes based on their toxicity and likelihood of occurrence in drug products:
| Class | Elements | Risk Level | Requirement |
|---|---|---|---|
| Class 1 Highest Toxicity |
As, Cd, Hg, Pb | Significant toxicity in all routes of administration | Must always be evaluated for all drug products |
| Class 2A High Toxicity |
Co, Ni, V | High toxicity; relatively high probability of occurrence | Risk assessment required; analyse if indicated |
| Class 2B High Toxicity |
Ag, Au, Ir, Os, Pd, Pt, Rh, Ru, Se, Tl | High toxicity; low natural occurrence | Analyse if intentionally added or risk assessment indicates |
| Class 3 Low Toxicity |
Ba, Cr, Cu, Li, Mo, Mn, Sb, Sn | Relatively low toxicity via oral route; higher by parenteral/inhalation | Evaluate for parenteral/inhalation products; oral generally safe |
USP ⟨232⟩ — Concentration Limits
USP ⟨232⟩ sets concentration limits (μg/g) based on the maximum daily dose and route of administration. The limits are derived from ICH Q3D PDEs using the formula:
Concentration Limit (μg/g) = PDE (μg/day) ÷ Maximum Daily Dose (g/day)
Class 1 Element Limits (Oral Products)
| Element | PDE (μg/day) | Limit at 10 g/day dose (μg/g) | Option 1 Limit (μg/g) |
|---|---|---|---|
| Arsenic (As) | 15 | 1.5 | 1.5 |
| Cadmium (Cd) | 5 | 0.5 | 0.5 |
| Lead (Pb) | 5 | 0.5 | 0.5 |
| Mercury (Hg) | 30 (inorganic) / 10 (methylmercury) | 3.0 | 3.0 |
⚠️ Option 1 vs Option 2
Option 1: Uses a default maximum daily dose of 10 g/day — gives conservative fixed limits applicable to any product. Most labs use this approach for screening.Option 2: Uses the actual maximum daily dose of the specific product — gives product-specific limits. Used when the daily dose is known and Option 1 limits are too restrictive.
USP ⟨233⟩ — Analytical Procedures
USP ⟨233⟩ specifies two primary procedures for elemental impurity testing:
| Procedure | Technique | Best For |
|---|---|---|
| Procedure 1 | ICP-OES (Inductively Coupled Plasma – Optical Emission Spectroscopy) | Higher-concentration elements; less sensitive; simpler to operate |
| Procedure 2 | ICP-MS (Inductively Coupled Plasma – Mass Spectrometry) | Trace-level analysis; higher sensitivity; required for Class 1 elements at low limits |
📌 At NPRA
NPRA uses Procedure 2 (ICP-MS) with the Agilent 8900 ICP-QQQ for all heavy metal limit tests. The sub-ppb sensitivity of the ICP-MS is necessary to meet the low concentration limits for As, Cd, Pb, and Hg specified in USP ⟨232⟩.
System Suitability Requirements
Before running samples, USP ⟨233⟩ requires demonstration of system suitability:
| Requirement | Criteria | How to Verify |
|---|---|---|
| Standard Precision | RSD ≤ 20% (6 replicates at J level) | Run a standard at the specification limit (J) 6 times; calculate RSD |
| Calibration Linearity | Correlation coefficient ≥ 0.99 | Plot calibration curve with ≥ 5 standards; verify R ≥ 0.99 |
| Spike Recovery (Accuracy) | 70–150% recovery | Spike sample at J level; measure recovery (see Chapter 4) |
Method Validation Parameters
When validating an alternative procedure or applying USP ⟨233⟩ to a new matrix, the following validation parameters must be demonstrated:
- Accuracy: Spike recovery at 0.5J, J, and 1.5J levels. All must fall within 70–150%.
- Precision (Repeatability): RSD of 6 replicate preparations at J level. RSD ≤ 20%.
- Specificity: Demonstrate no interference from the sample matrix on target analytes.
- Limit of Quantitation (LOQ): Lowest concentration that can be quantified with acceptable precision and accuracy. Must be ≤ 0.5J.
- Range: Demonstrated from LOQ to at least 1.5J.
Permitted Daily Exposures (PDEs) — Complete Table
Reference table of PDEs from ICH Q3D for all 24 target elements by route of administration:
| Element | Class | Oral PDE (μg/day) | Parenteral PDE (μg/day) | Inhalation PDE (μg/day) |
|---|---|---|---|---|
| As | 1 | 15 | 15 | 2 |
| Cd | 1 | 5 | 2 | 2 |
| Hg | 1 | 30 | 3 | 1 |
| Pb | 1 | 5 | 5 | 5 |
| Co | 2A | 50 | 5 | 3 |
| Ni | 2A | 200 | 20 | 5 |
| V | 2A | 100 | 10 | 1 |
| Ag | 2B | 150 | 10 | 7 |
| Au | 2B | 100 | 100 | 1 |
| Ir | 2B | 100 | 10 | 1 |
| Os | 2B | 100 | 10 | 1 |
| Pd | 2B | 100 | 10 | 1 |
| Pt | 2B | 100 | 10 | 1 |
| Rh | 2B | 100 | 10 | 1 |
| Ru | 2B | 100 | 10 | 1 |
| Se | 2B | 150 | 80 | 130 |
| Tl | 2B | 8 | 8 | 8 |
| Ba | 3 | 1400 | 700 | 300 |
| Cr | 3 | 11000 | 1100 | 3 |
| Cu | 3 | 3000 | 300 | 30 |
| Li | 3 | 550 | 250 | 25 |
| Mo | 3 | 3000 | 1500 | 10 |
| Mn | 3 | 2500 | 250 | 25 |
| Sb | 3 | 1200 | 90 | 20 |
| Sn | 3 | 6000 | 600 | 60 |
Documentation & Audit Trail
Regulatory compliance requires comprehensive documentation. Ensure the following records are maintained:
- Instrument logbook: Daily startup, tune files, performance reports, maintenance records.
- Standard preparation records: Lot numbers, expiry dates, preparation dates, dilution details.
- Sample preparation records: Weights, volumes, digestion programmes, spike details.
- Calibration data: Calibration curves, R² values, CCV/CCB results.
- Results: Raw data files, ISTD recovery, spike recovery calculations, final reported values.
- MassHunter audit trail: The software's built-in audit trail tracks all data modifications — ensure it is enabled and not overridden.
💡 Audit Readiness
Keep all records organised chronologically and accessible for inspection. During GMP audits, inspectors will verify that:
- The instrument was calibrated and performing within specification on the day of analysis.
- Standards were traceable to certified reference materials.
- Spike recoveries met 70–150% for every batch.
- QC checks (CCV/CCB) were within limits throughout the run.
- Data integrity is maintained — no unauthorised modifications.